Skip to main content
Equibles

Daniel Wendorff

Analyst

Equibles does not estimate personal net worth.

About Daniel Wendorff

Daniel Wendorff has spoken on 1 investor event across 1 company, most recently for Qiagen N.V. on March 10, 2026. The companies whose calls Daniel Wendorff spoke on are classified in the Healthcare sector.

Daniel Wendorff on recent calls

“So the CHI Sprint is mainly targeting our research customers. So high throughput sample preparation for our research customers. But you're right, the CHI Symfony Connect we have in particular developed for our liquid biopsy customers.”
Barclays Global Healthcare Conference ·

Company network

Recent activity